CPP
LLY icon

Crow Point Partners’s Eli Lilly LLY Stock Holding History

Crow Point Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$403K Sell
4,810
-3,890
-45% -$328K 0.06% 124
2015
Q2 		$726K Buy
8,700
+200
+2% +$15.2K 0.11% 90
2015
Q1 		$618K Buy
+8,500
New +$605K 0.08% 97
2014
Q3 		$453K Sell
6,980
-520
-7% -$32.9K 0.06% 135
2014
Q2 		$441K Hold
7,500
– – 0.06% 131
2014
Q1 		$441K Buy
+7,500
New +$419K 0.06% 131

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Crow Point Partners's LLY Position: Q3 2015 in Review

Crow Point Partners reduced its Eli Lilly (LLY) stake by 45% in Q3 2015, selling an estimated $328K and leaving 4,810 shares worth $403K. The position accounts for 0.06% of the portfolio, ranked #124.

Crow Point Partners first reported a position in LLY in Q1 2014 and has held it in 6 quarters since. The position peaked at $726K in Q2 2015. 1,148 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

  • Crow Point Partners held 4,810 shares of Eli Lilly worth $403K as of Q3 2015.
  • Crow Point Partners sold 3,890 Eli Lilly shares in Q3 2015, an estimated $328K.
  • Eli Lilly made up 0.06% of Crow Point Partners's portfolio in Q3 2015, its #124 holding.
  • Crow Point Partners first reported a position in Eli Lilly in Q1 2014 and has held it in 6 quarters since.
  • Crow Point Partners's Eli Lilly position peaked at $726K in Q2 2015.
  • 1,148 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Crow Point Partners's 13F filing for Q3 2015, filed 17 Dec 2015.